Bloom Energy Stock (BE) Is Rising 6% in Friday’s After-Hours Trading – Here’s Why
Bloom Energy ($BE) stock jumped about 6% in Friday’s extended trading session after the S&P Dow Jones Indices announced its addition to the S&P 500...
Corcept Therapeutics Inc (CORT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 5,261,628 | $457,498,555 | -8% | 0.63% |
| 2. | AQR Capital Management Cliff Asness | 2,582,561 | $224,553,662 | +536% | 0.08% |
| 3. | Tang Capital Management Kevin C. Tang | 1,500,000 | $130,425,000 | 5.92% | |
| 4. | D E Shaw D. E. Shaw | 883,001 | $76,776,937 | -26% | 0.04% |
| 5. | BioImpact Capital Mpm Capital | 771,028 | $67,040,885 | -22% | 4.09% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $33.56 | 24,218 | $812,836.00 | 1,146,631 | 2026-03-17 | Filing | |
| $33.00 | 75,782 | $2,500,972.72 | 1,122,413 | 2026-03-17 | Filing | |
| $21.53 | 100,000 | $2,153,000.00 | 3,308,303 | 2021-06-11 | Filing | |
| $21.53 | 50,000 | $1,076,500.00 | 1,046,838 | 2021-06-11 | Filing | |
| $22.64 | 68 | $1,539.52 | 3,208,303 | 2020-12-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $115.61 | 2,281 | $263,710.52 | 9,755 | 2026-09-01 | Filing | |
| $114.71 | 10,989 | $1,260,567.97 | 12,036 | 2026-09-01 | Filing | |
| $113.94 | 11,730 | $1,336,458.72 | 23,025 | 2026-09-01 | Filing | |
| $115.44 | 1,225 | $141,413.39 | 4,242 | 2026-09-02 | Filing | |
| $114.58 | 5,621 | $644,042.38 | 5,467 | 2026-09-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,432,023 | $1,080,964,444 | 0.02% | |
| 2. | 5,044,638 | $438,631,274 | 0.02% | |
| 3. | 4,172,482 | $362,797,310 | 0.01% | |
| 4. | 3,962,177 | $344,511,290 | 5.25% | |
| 5. | 3,337,618 | $290,205,885 | 0.01% |
News See All
Blowing Past the Street: 46 Stocks That Crushed Q2 EPS Projections
More than 250 companies announced their earnings performance in the second quarter of the year on Wednesday, July 29, offering a fresh look at how they performed relative to what the market expected of...
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2026 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2026 Earnings Call Transcript May 1, 2026 Operator: Thank you for standing by, and welcome to Corcept Therapeutics First Quarter 2026 Earnings Conference...
Corcept (CORT) Upgraded After Key Regulatory Approval for Lifyorli
Corcept Therapeutics Incorporated (NASDAQ:CORT) ranks among the most profitable biotech stocks to buy now.
10 Most Profitable Biotech Stocks to Buy Now
In this article, we will take a look at the 10 Most Profitable Biotech Stocks to Buy Now.
10 Best Biotech Stocks with Highest Upside Potential
In this article, we will take a look at some of the best biotech stocks that are currently offering attractive upside to investors. On April 16, reports from J.P.
7 Best Stocks to Buy for Short Term
In this article, we will take a look at the best stocks to buy for the short term. In a continuously evolving market, investing has become a game of timing and informed decision-making.
Corcept Therapeutics (CORT) Climbs 19.7% as Lifyorli Gets FDA OK
Corcept Therapeutics Inc. (NASDAQ:CORT) is one of the 10 Stocks Investors Are Buying Now.
10 Stocks Investors Are Buying Now: Chewy, Braze, Sarepta, and More
Ten stocks boasted a double-digit rally on Wednesday, mimicking a broader market optimism, helped by expectations of easing tensions in the Middle East.
H.C. Wainwright Cuts Corcept Therapeutics Incorporated (CORT) Price Target, Keeps Buy Rating
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best under-the-radar stocks to buy according to hedge funds. On February 25, H.C.
Hedge Fund Resource Center